| Location |
Symbol |
Title |
MIM # |
Disorder |
Comments |
Method |
Mouse |
| Xp11.23 |
CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2 |
Calcium channel, voltage-dependent, alpha-1F subunit |
300110 |
Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3) |
|
REn, Fd |
|
| Xp11.23 |
FTSJ1, JM23, SPB1, MRX44, MRX9 |
FTSJ homolog 1 |
300499 |
Mental retardation, X-linked-9, 309549 (3) |
|
REc |
|
| Xp11.23 |
GAGE1 |
G antigen 1 |
300594 |
|
|
Psh, A, REc |
|
| Xp11.23 |
GAGE2A |
G antigen 2A |
300720 |
|
|
REc |
|
| Xp11.23 |
GAGE2B |
G antigen 2B |
300726 |
|
|
REc |
|
| Xp11.23 |
GAGE2C, GAGE2 |
G antigen 2C |
300595 |
|
|
Psh, A, REc |
|
| Xp11.23 |
GAGE2D |
G antigen 2D |
300735 |
|
|
REc |
|
| Xp11.23 |
GAGE2E |
G antigen 2E |
300736 |
|
|
REc |
|
| Xp11.23 |
GAGE7 |
G antigen 7 |
300601 |
|
|
REc |
|
| Xp11.23 |
GAGE7B |
G antigen 7B |
300637 |
|
|
Psh, A, REc |
|
| Xp11.23 |
GAGE10 |
G antigen 10 |
300737 |
|
|
REc |
|
| Xp11.23 |
GAGE12C |
G antigen 12C |
300727 |
|
|
REc |
|
| Xp11.23 |
GAGE12D |
G antigen 12D |
300728 |
|
|
REc |
|
| Xp11.23 |
GAGE12E |
G antigen 12E |
300729 |
|
|
REc |
|
| Xp11.23 |
GAGE12F |
G antigen 12F |
300730 |
|
|
REc |
|
| Xp11.23 |
GAGE12G |
G antigen 12G |
300731 |
|
|
REc |
|
| Xp11.23 |
GAGE12H |
G antigen 12H |
300732 |
|
|
REc |
|
| Xp11.23 |
GAGE12J |
G antigen 12J |
300733 |
|
|
REc |
|
| Xp11.23 |
GAGE13 |
G antigen 13 |
300734 |
|
|
REc |
|
| Xp11.23 |
GATA1, GF1, ERYF1, NFE1, XLTT |
GATA-binding protein-1 (globin transcription factor-1) |
305371 |
Dyserythropoietic anemia with thrombocytopenia, 300367 (3);Macrothrombocytopenia, 300367 (3); Leukemia, megakaryoblastic, with or without Down syndrome, 190685 (3); Leukemia, megakaryoblastic, of Down syndrome, 190685(3); Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3); Anemia, X-linked, without thrombocytopenia (3) |
|
REa, A |
X(Gf1) |
| Xp11.23 |
HDAC6 |
Histone deacetylase 6 |
300272 |
|
|
R, A |
|